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Grant M Russell6, Barbara Workman7, Leon Flicker8, Martin P Eccles9 and Sally E Green1Abstract
Background: Dementia is a growing problem, causing substantial burden for patients, their families, and society.
General practitioners (GPs) play an important role in diagnosing and managing dementia; however, there are gaps
between recommended and current practice. The aim of this study was to explore GPs’ reported practice in
diagnosing and managing dementia and to describe, in theoretical terms, the proposed explanations for practice
that was and was not consistent with evidence-based guidelines.
Methods: Semi-structured interviews were conducted with GPs in Victoria, Australia. The Theoretical Domains
Framework (TDF) guided data collection and analysis. Interviews explored the factors hindering and enabling
achievement of 13 recommended behaviours. Data were analysed using content and thematic analysis. This paper
presents an in-depth description of the factors influencing two behaviours, assessing co-morbid depression using a
validated tool, and conducting a formal cognitive assessment using a validated scale.
Results: A total of 30 GPs were interviewed. Most GPs reported that they did not assess for co-morbid depression
using a validated tool as per recommended guidance. Barriers included the belief that depression can be adequately
assessed using general clinical indicators and that validated tools provide little additional information (theoretical domain
of ‘Beliefs about consequences’); discomfort in using validated tools (‘Emotion’), possibly due to limited training and
confidence (‘Skills’; ‘Beliefs about capabilities’); limited awareness of the need for, and forgetting to conduct, a depression
assessment (‘Knowledge’; ‘Memory, attention and decision processes’). Most reported practising in a manner consistent
with the recommendation that a formal cognitive assessment using a validated scale be undertaken. Key factors enabling
this were having an awareness of the need to conduct a cognitive assessment (‘Knowledge’); possessing the necessary
skills and confidence (‘Skills’; ‘Beliefs about capabilities’); and having adequate time and resources (‘Environmental context
and resources’).
Conclusions: This is the first study to our knowledge to use a theoretical approach to investigate the barriers and
enablers to guideline-recommended diagnosis and management of dementia in general practice. It has identified key
factors likely to explain GPs’ uptake of the guidelines. The results have informed the design of an intervention
aimed at supporting practice change in line with dementia guidelines, which is currently being evaluated in a
cluster randomised trial.
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Dementia is an increasingly prevalent, global problem
that results in substantial health, social and financial
consequences for the individuals affected, their care-
givers, and society [1]. The worldwide estimate of the
number of people with dementia in 2010 was 35.6 mil-
lion, and this is projected to increase to 115 million by
2050 [2]. In Australia, there are approximately 298,000
people living with dementia and this is expected to reach
900,000 by 2050 [3].
General practitioners (GPs) play an important role in
the detection and management of dementia. They are
generally the first point of contact for patients with sus-
pected cognitive impairment or dementia, and they are
often primarily responsible for the ongoing management
of the patient once a diagnosis has been confirmed [4-7].
Early detection of symptoms can allow reversible causes
of cognitive decline to be addressed and co-morbidities,
such as depression, to be identified and managed. Early
diagnosis of dementia enables access to education, support
and counselling services to assist patients and carers, and
also provides patients and carers with the opportunity and
time to plan for the future and organise their personal and
financial affairs [8-11]. Early access to dementia-modifying
medication, such as acetyl-cholinesterase inhibitors, can
produce symptomatic benefits for some patients and may
result in an increase in functionality [8-10,12].
Evidence-based guidelines for the detection, diagnosis
and management of dementia relevant to primary care,
such as those published by the Scottish Intercollegiate
Guidelines Network (SIGN) [13], are accessible to prac-
titioners through various sources including guideline
clearinghouses and guideline development organisation
websites. These guidelines include a series of evidence-
based recommendations for investigations and interven-
tions which, if followed, optimise the health outcomes
for people with dementia. The SIGN-recommended
investigations and interventions include: conducting a for-
mal cognitive assessment using the Mini-Mental State
Examination (MMSE) in individuals with suspected cogni-
tive impairment; assessing for co-morbid depression using
a validated tool; use of structural imaging (e.g., brain CT) in
the diagnostic workup of patients with suspected dementia;
access to dementia-modifying medication in patients with
confirmed dementia; provision of caregiver support and
training; and promotion of cognitive stimulation and recre-
ational activities. A systematic search of dementia guide-
lines published after the SIGN guideline conducted by our
team identified 14 guidelines, the majority of which share
the same recommendations as SIGN.
Despite availability and dissemination of guidelines for
diagnosis and management of dementia, gaps between
recommended and current practice still exist [14-20].
For example, a study of dementia care in the US foundthat concordance with a number of dementia care
process measures (drawn from guideline recommenda-
tions) ranged from 9% to 79%, with concordance for 11
of these processes being less than 40% [15]. Formal
cognitive assessment may not be conducted in as many
as 30% to 50% of cases [15,18]. Similar findings have
been reported in relation to assessment for co-morbid
depression in patients being evaluated for dementia
[15,16,18]. Data from Australian studies suggests that
formal cognitive testing is not conducted to the extent
recommended [14,20].
A systematic review of barriers to physicians’ use of
guidelines has identified a number of factors that may
influence uptake, including lack of awareness or familiarity
with guidelines, lack of agreement, lack of self-efficacy, lack
of outcome expectancy, the inertia of previous practice, and
external barriers to guideline use [21]. A systematic review
specifically focussing on barriers to recommended diagnosis
and management of dementia in primary care has also
identified several influences on primary care practitioners’
practice [22]. These include lack of support, time con-
straints, financial constraints, stigma associated with diag-
nosis, diagnostic uncertainty, insufficient knowledge or
experience, and difficulties disclosing the diagnosis. While
these go some way to explaining the practice gap, none of
the studies used theory to investigate the causes of imple-
mentation difficulties. Use of theory has been advocated to
facilitate a comprehensive assessment of mediators of be-
haviour change for designing interventions that are most
likely to bring about behaviour change [23,24]. Additionally,
few studies in the systematic review explored the causes
of implementation difficulties specifically in relation to
individual recommendations described in behavioural
terms (i.e., who needs to do what, how and where); this
may have limited the accuracy and/or specificity of the
barriers identified.
Theory provides an explicit statement of the structural
and psychological processes that are hypothesised to influ-
ence behaviour and, as such, is useful for investigating im-
plementation difficulties, informing the design of practice
change interventions and contributing to the evidence base
on which to select interventions [23-25]. Theory can
provide information about the mechanisms involved in
clinician behaviour change, and these mechanisms can be
systematically investigated and targeted with behaviour
change techniques and components to bring about change.
If assessments of implementation difficulties are not under-
taken within a theoretical approach, then the resulting in-
terventions are likely to be limited to pragmatic rather than
generalisable solutions, and opportunities to investigate the
mediating pathways of behaviour change and optimise
interventions will be limited [26].
Many theories are available to guide the assessment
of implementation difficulties and for understanding
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make theory more accessible to those interested in im-
plementation and behaviour change, the Theoretical
Domains Framework (TDF) was developed by a team
of psychology theorists in collaboration with imple-
mentation researchers. The TDF represents an inte-
grated theoretical framework of a number of domains
and theoretical constructs synthesised from 33 theories
and 128 constructs, which can be used to identify the-
oretical explanations for implementation difficulties
and to inform the design of implementation interven-
tions [28]. The TDF includes 12 theoretical domains:
‘Knowledge’, ’Skills’, ‘Social/professional role and iden-
tity’, ‘Beliefs about capabilities’, ‘Beliefs about conse-
quences’, ‘Motivation and goals’, ‘Memory, attention
and decision processes’, ‘Environmental context and
resources’, ‘Social influences’, ‘Emotion’, ‘Behavioural
regulation’ and ‘Nature of the behaviours.’ Since this
study was completed, the TDF has been independently
validated to confirm the optimal domain structure,
content and labels of the framework [29]. To date, a
number of empirical studies have used the TDF to ex-
plore implementation problems in different clinical
areas [30], including low back pain [26,31-33], hand hygiene
[34,35], blood transfusion [36,37], medication prescribing
[38], and schizophrenia [39] but not dementia.
The aim of this study was to use the TDF to explore
GPs’ reported practice in relation to the diagnosis and
management of dementia and to describe, in theoretical
terms, the proposed explanations for practice that was
and was not consistent with recommended guidance.
The study is the first phase of a larger cluster rando-
mised trial testing the effectiveness of a theory-informed
intervention to increase GPs’ uptake of a dementia
guideline in general practice, ‘Investigating Research Im-
plementation Strategies for the care of older adults with
suspected cognitive impairment’ (IRIS) [40]. This paper
describes reported practices and theoretical explanations
in relation to two key diagnostic recommendations of
the SIGN guideline (with level B evidence) for which
there are identified evidence-practice gaps [13]. These
practices constitute primary targets for behaviour
change in the IRIS intervention. The SIGN recommen-
dations are: conducting a formal cognitive assessment
using the MMSE in individuals with suspected cogni-
tive impairment, and assessing for co-morbid depres-
sion using a validated tool. The results of the current
qualitative study have been used to design the IRIS
intervention by targeting the identified barriers and
enablers with inclusion of relevant behaviour change
techniques. A description of the development and
content of the IRIS intervention and the subsequent
cluster randomised trial findings will be reported
separately.Methods
Design
Qualitative study using semi-structured interviews based
on the TDF.
Participants and setting
GPs managing people with suspected cognitive impair-
ment or dementia and practising in the Australian state
of Victoria. Suspected cognitive impairment or dementia
was defined by the GPs.
Procedure
The contact details of a random sample of GPs practis-
ing in the Australian state of Victoria, sampled equally
from two geographical strata (metropolitan, regional/
rural), was supplied by the Australian Medical Publish-
ing Co (AMPCo), a subsidiary of the Australian Medical
Association, which provides lists of Australian medical
practitioners. An invitation to participate (including ex-
planatory statement and consent form) was mailed, in
batches of 100, to 700 GPs in the sampling frame. GPs
currently managing people with suspected cognitive im-
pairment or dementia and wishing to participate opted
in to the study by returning a signed consent form. Data
collection commenced as soon as GPs opted into the
study, and analysis occurred after each interview. Re-
cruitment continued to the point where data saturation
was achieved and no new information was forthcoming.
Participants took part in a single, one-hour interview
with an experienced qualitative researcher (KM), either
face-to-face in their practice rooms or by telephone. An
interview guide with questions and prompts informed by
the TDF guided the discussion. The interviews focused
on the diagnosis and management recommendations
from the SIGN guideline, with some adaptation for the
Australian context, together with recommendations that
were considered best practice by the IRIS clinical inves-
tigators (Table 1). The interviews were audio-taped and
transcribed verbatim. Transcriptions were cross-checked
against the audio recordings for accuracy and de-identified.
Participants were provided with a copy of their interview
transcription and invited to check it for accuracy and return
any amendments. Participants were offered an honorarium
to cover the costs associated with their participation and
could claim Continuing Professional Development points
for their participation.
Interview guide
The interview guide (see Additional file 1) covered the
13 recommended behaviours outlined in Table 1. GPs
were first asked general questions about how they
became aware of patients with suspected cognitive im-
pairment or dementia and what steps they then took.
They were also asked about each of the recommended
Table 1 Diagnosis and management recommendations investigated
Recommendation Details and source
Conduct a formal cognitive assessment using a validated scale (e.g.,
MMSE) in individuals with suspected cognitive impairment.
SIGN guideline recommends the MMSE should be used for cognitive
testing of individuals with suspected cognitive impairment (Grade B
recommendation).
Assess for co-morbid depression using a validated tool (e.g., Geriatric
Depression Scale or others).
SIGN guideline recommends considering the presence of co-morbid depression
as part of the assessment for suspected dementia (Grade B recommendation).
Evidence underpinning the guideline advocates use of validated tools for
assessing depression (e.g., Geriatric Depression Scale).
Refer for pathology testing. This is a SIGN guideline good practice point. Supported by other guidelines
and considered best practice by the IRIS clinical investigators to facilitate
exclusion of potentially reversible causes of dementia.*
Refer for head/brain computed tomography (CT) scan. SIGN guideline recommends structural imaging should form part of the
diagnostic work up of patients with suspected dementia (Grade C
recommendation). We focus only on referral for CT scan since GPs in Australia
cannot refer for a Medicare rebatable magnetic resonance imaging (MRI).
Review current medication (prescription and over the counter) that
may cause cognitive impairment.
Not a recommendation of the SIGN guideline. Supported by other guidelines
and considered best practice by the IRIS clinical investigators to eliminate
possible other causes of dementia-like symptoms.*
Disclose or reinforce a diagnosis of dementia. Not a recommendation of the SIGN guideline. The SIGN guideline
recommends that healthcare professionals should be aware that many
people with dementia can understand their diagnosis, receive information,
and be involved in decision making (Grade C recommendation); that some
people with dementia may not wish to know their diagnosis (Grade C
recommendation); and that in some situations disclosure of a diagnosis
of dementia may be inappropriate (Grade D recommendation). Supported
by other guidelines and considered best practice by the IRIS clinical
investigators.*
Refer to specialist (including via Cognitive, Dementia and Memory
Service [CDAMS]) for access to dementia-modifying medications.
SIGN guideline makes recommendations about specific pharmacological
interventions (e.g., use of cholinesterase inhibitors) (Grade B recommendations).
Access to dementia-modifying medication is via specialist referral
in Australia.
Provide information on, or refer for, recreational activities. SIGN guideline recommends that recreational activities should be encouraged
to enhance the quality of life and well-being of people with dementia (Grade
B recommendation). Recreational activities may include current or previous
interests or the introduction of new recreational activities. Alzheimer’s Australia
offer education and training and facilitate support groups for people with
dementia and their carers.
Provide information on, or refer for, activities to promote cognitive
stimulation.
SIGN guideline recommends that cognitive stimulation should be offered to
people with dementia (Grade B recommendation). Cognitive stimulation may
occur through participation in recreational activities, via support from a carer
or through formal cognitive stimulation activities. Alzheimer’s Australia offer
education and training and facilitate support groups for people with dementia
and their carers.
Provide, or refer for, caregiver training. SIGN guideline recommends that caregivers should receive training on
interventions that are effective for people with dementia (Grade B
recommendation). Alzheimer’s Australia offer education and training and
facilitate support groups for people with dementia and their carers.
Give advice re. respite care. Not a recommendation of the SIGN guideline. Supported by other guidelines
and considered best practice by the IRIS clinical investigators.*
Promote awareness of changing driving capacity as disease
progresses.
Not a recommendation of the SIGN guideline. Supported by other guidelines
and considered best practice by the IRIS clinical investigators.*
Discussion of legal issues. Not a recommendation of the SIGN guideline. Supported by other guidelines
and considered best practice by the IRIS clinical investigators.*
*Recommendations considered best practice by the IRIS clinical investigators, arrived at through discussion and consensus.
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and the factors that hindered or enabled achievement
of the behaviours. The interview guide was based on
the TDF and was developed by a multi-disciplinary
team, including investigators with clinical expertise indementia management and those with expertise in be-
haviour change and implementation research. The
interview guide was piloted with three GPs prior to
data collection to assess its comprehensiveness, prac-
ticability and acceptability.
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The interview transcripts were analysed using content
analysis after each interview, and both the manifest and
latent content was examined [41-43]. First, the nature ofFigure 1 Nature of reported practice and factors perceived to influen
cognitive assessment using a validated scale (e.g., MMSE).participants’ current practice in relation to each of the
recommended behaviours was identified, and the data
were categorised on the basis of the identified groupings
(Figure 1). For example, data from GPs reporting theyce practice for recommended behaviour 1: conduct a formal
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patients they suspected of having cognitive impairment
were coded alike based on their reported practice. The
data for each grouping were then examined to look for
consistencies and variations to ascertain whether it could
be classified further. Next, the data in each grouping
were content analysed to identify the factors perceived
to influence the achievement of the recommended be-
haviours (i.e., barriers and enablers). These factors were
then thematically mapped to the domains of the TDF to
enable identification of possible theoretical explanations
for practice that was and was not consistent with recom-
mended guidance. Metropolitan and regional/rural inter-
views were analysed separately to investigate geographic
variations.
The development of the coding frame and initial ana-
lysis of interview data was undertaken by the researcher
who conducted the interviews, and a random subset of
20% of interviews was independently coded and analysed
by a second researcher with expertise in qualitative
methods as a method of verification of the initial ana-
lysis. The thematic analysis of the factors to the TDF
was conducted by the researcher who conducted the
interviews and checked by a second researcher with expert-
ise in the TDF. Coding by the independent researchers was
compared manually, and any discrepancies were discussed
until agreement was reached. Few discrepancies between
coders were identified.
Ethics
This study was approved by the Monash University Human
Research Ethics Committee (MUHREC) - Project Number:
CF08/1291 – 2008000627.
Results
Participants
A total of 30 GPs (18 male, 12 female) who reported that
they manage people with suspected cognitive impair-
ment or dementia from 30 general practices throughout
Victoria, Australia (13 metropolitan, 17 regional/rural),
participated in the study (4% of GPs invited). Partici-
pants varied in terms of years since graduation from
medical training (mean 28.00 years, SD 8.95 years), prac-
tice size (11 solo, 19 group; median practice size 2, range
1 to 11), and number of patients in their care with a
confirmed diagnosis of dementia (ranging from 0 to 25).
In total, 24 interviews were conducted face-to-face.
Conducting a formal cognitive assessment using a
validated scale (e.g., MMSE) (recommended behaviour 1)
This study identified a range of clinical behaviours that GPs
engage in relating to the conduct of a formal cognitive as-
sessment in patients with suspected cognitive impairment.
These were classified into five categories (Figure 1):Category 1. GP conducts a formal cognitive assessment
using a validated scale (MMSE).
Category 2. GP assesses cognitive function by other
clinical methods (not using a validated tool).
Category 3. GP refers the patient to a specialised Aged
Care Assessment Service (ACAS) for a cognitive
assessment (i.e., GP does not conduct a cognitive
assessment) [ACAS comprises a team of health
professionals who conduct assessments of older
people to assist them to gain access to services most
appropriate to meet their care needs. ACAS is
publically funded in Australia].
Category 4. GP refers the patient to a specialist for
assessment (i.e., GP does not conduct a cognitive
assessment).
Category 5. No cognitive assessment is conducted, and
no referral to another health professional or service for
this assessment is initiated by the GP.
For the vast majority of GPs in this study, assessing
the cognitive function of their patients either themselves
or via their practice nurse was their normal procedure.
In almost all cases, this was done using a MMSE, or
similar validated scale (Category 1), rather than assessing
the patient using other clinical criteria (Category 2). In
contrast, referring a patient to ACAS or a specialist for
assessment (Categories 3 and 4) was a situation-specific
practice, in that it occurred with some patients in certain
situations and was not undertaken in all situations by
GPs who described doing this. In different circum-
stances, or with different patients, the GP may conduct
the assessment themselves. However, a small number
of the GPs preferred to routinely have their patients
assessed by a third party (ACAS, specialist) for various
reasons (discussed below) (Category 3 and 4). Not con-
ducting a cognitive assessment (Category 5) occurred
when a GP was unable, or decided not, to assess a pa-
tient’s cognitive function at a certain time, although they
may do so at a later time. Again, this practice was gener-
ally situation-specific.
The factors perceived to influence the behaviour of
GPs in each category are described below and sum-
marised in Figure 1. The barriers and enablers that were
elicited through the interviews and identified via content
analysis were then thematically mapped to the relevant
theoretical domains of the TDF [28]. Illustrative quotes
from participants are provided where relevant.
Factors perceived to influence practice, mapped to the TDF
Category 1. GP conducts a formal cognitive assessment
using a validated scale (MMSE)
The main factors enabling the conduct of a formal cogni-
tive assessment using the MMSE were an awareness of the
need to assess cognitive function in patients in whom
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with an awareness of the appropriate test to use (Know-
ledge), being able to access the test (Environmental context
and resources), and knowing how to and being confident
in administering it (Skills; Beliefs about capabilities).
Another important factor was having the time needed,
or the availability of a practice nurse, to conduct the
test (Environmental context and resources).
The advantages of a practice nurse are apparent in the
comment made by one GP: ‘If I feel anything is serious I
say, “look let’s do a formal memory test for you” … and we
have the facility of a practice nurse who can go out and do
home health assessments, and they usually do a formal
Mini Mental test on the patient’ (GP 20 – Metro).
For most of these GPs the conduct of a cognitive as-
sessment was a routine part of a dementia assessment
process (Behavioural regulation), as the following com-
ment indicates: ‘Okay, well the first thing I’d do is do a
Mini Mental’ (GP 12 – Metro).Category 2. GP assesses cognitive function through use of
other clinical criteria
A common reason cited for preferring to assess patients
through use of other clinical criteria rather than using a val-
idated scale was a belief that patients found responding to
validated cognitive assessments, such as the MMSE, embar-
rassing or uncomfortable (Beliefs about consequences;
Social Influences). As one GP explained: ‘Oh, they just get
embarrassed, and the questions are a bit demeaning, I
think. If I was asked those questions, I’d be a bit insulted’
(GP 13 – Rural).
Other reasons were that they either believed that a
MMSE was not a good measure of cognitive function
(particularly with patients from non-English speaking
backgrounds) (Beliefs about consequences), or that they
believed they could assess cognitive function through
use of other clinical criteria (Beliefs about capabilities for
performing a competing behaviour) and that a MMSE
did not necessarily provide additional useful information
(Beliefs about consequences). The latter view is reflected
in the following statement: ‘Oh sometimes I do an MMSE.
… I don’t find it that useful. I mean … from conversation
you can really find which way they’re going. I mean… so
the MMSE is … it doesn’t give me additional information I
find’ (GP 25 – Metro).
Another barrier to the use of a validated tool when
conducting a cognitive assessment was the discomfort
some GPs reported experiencing when using such a tool
with patients (Emotion), possibly due to lack of training
or experience in its use (Skills). In a few cases, lack of
access to, or lack of knowledge of how to access, a vali-
dated tool such as the MMSE were the reasons cited for
not using one (Environmental context and resources).Category 3. GP refers to an aged care assessment service
(ACAS) for cognitive assessment
Lack of time or resources (Environmental context and
resources) was cited as one of the main reasons for a GP
referring a patient to an ACAS for a cognitive assess-
ment. An ACAS assessment was often needed for other
reasons (e.g., assessment for eligibility for other services
such as assistance in the home, respite care, or place-
ment in an aged care facility) and, as it was believed a
cognitive assessment formed part of this process, it was
expedient for the GP to refer for a general ACAS assess-
ment and not conduct a cognitive assessment himself
(Beliefs about consequences): ‘To do a cognitive assess-
ment, I think we do as an informal thing. When we
believe that there’s a problem then … that’s where the
memory clinic or the aged care assessment team come
in’ (GP 02 – Rural).
Other reasons cited for having the cognitive assess-
ment conducted by someone else was a preference for
having it administered by an independent third party
who would not influence the result (Beliefs about conse-
quences). One GP saw it as providing an unbiased assess-
ment: ‘Yeah we do [a cognitive assessment]. Although what
I try to do is get someone else to do it for me so I’m not
biased’ (GP 09 - Rural).
Another reason for the GP referring elsewhere to have
the cognitive assessment carried out was a belief that it was
uncomfortable for the patient to have their GP conduct it
(Beliefs about consequences; Social influences). Some GPs
may have preferred someone else to undertake the assess-
ment because they themselves were uncomfortable con-
ducting the assessment with their patients owing to the
embarrassment it caused for both parties (Emotion), pos-
sibly due to lack of skills and confidence (Skills; Beliefs
about capabilities).
Category 4. GP refers to a specialist for assessment without
conducting a cognitive assessment
The reported reasons for referral to a specialist for
assessment without conducting a cognitive assessment
were similar to the reasons for referring to ACAS, par-
ticularly in terms of preferring to have a third party con-
duct the assessment, and patient/GP discomfort (Beliefs
about consequences; Social influences; Emotion; Skills;
Beliefs about capabilities). The main difference was that
in some cases the referral occurred because the patient
or carer had requested a specialist assessment and the
GP was complying with their wishes (Social influences).
The GP believed that there was no need for them to
conduct a cognitive assessment in this case as the results
would not affect the referral decision and the specialist
would conduct a formal cognitive assessment anyway.
As one GP stated: ‘No, I don’t do that on everybody. …
If it’s clear that the family members want a referral to
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referral process’ (GP 03 - Rural).
In some instances a formal cognitive assessment was
considered unnecessary when the cognitive impairment
appeared obvious (Beliefs about consequences): ‘And some-
times, you know, I don’t need Mini Mental when it’s clearly
the problem. Then I will generally refer them on to the
geriatrician, or psycho-geriatrician …’ (GP 21 – Metro).
Category 5. No cognitive assessment conducted by GP
In situations where no cognitive assessment was con-
ducted, the main reason reported by participants was pa-
tient or carer refusal (Social influences). The other
reason cited for not conducting a cognitive assessment
was that the patient’s actual or suspected cognitive im-
pairment wasn’t considered as problematic at the time,
either by the GP, patient or carer, such that the GP
decided it didn’t warrant further investigation by way
of cognitive assessment (Beliefs about consequences). AFigure 2 Nature of reported practice and factors perceived to influen
depression using a validated tool (e.g., GDS).patient’s other illnesses or life expectancy may also be
taken into consideration (Beliefs about consequences).
One GP believed that patients were able to self-report
cognitive impairment without the need to conduct a for-
mal cognitive assessment (Beliefs about consequences).
No differences were found between metropolitan and
regional/rural GPs in terms of their reported practice
and key influencing factors in relation to the conduct of
cognitive assessments for patients with suspected cogni-
tive impairment or dementia.Assessing co-morbid depression using a validated tool
(recommended behaviour 2)
A range of clinical behaviours engaged in by GPs
relating to the assessment of co-morbid depression in
patients with suspected cognitive impairment were
identified. These were classified into three categories
(Figure 2):ce practice for recommended behaviour 2: assess co-morbid
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validated tool.
Category 2. GP assesses co-morbid depression using
general clinical indicators.
Category 3. Co-morbid depression not assessed by GP.
Unlike the situation with cognitive assessment, the GPs
usually did not refer a patient elsewhere specifically for as-
sessment of co-morbid depression, although this may have
occurred by default when a patient was referred to ACAS
or a specialist for a cognitive assessment.
Awareness that assessment for co-morbid depression
should form part of the dementia diagnosis process was
not as high amongst GPs as was their awareness of
the need to conduct a cognitive assessment. While many
GPs reported undertaking some form of depression
assessment, in most situations they preferred to assess
depression through general clinical indicators (Category
2) rather than by using a validated tool (Category 1). In
a large number of cases, the GPs reported that no as-
sessment of co-morbid depression was undertaken. The
factors perceived to influence practice for each category
are described below and summarised in Figure 2.Factors perceived to influence practice, mapped to the TDF
Categories 1 and 2. GP assesses co-morbid depression
The main factors influencing whether a patient with sus-
pected cognitive impairment was assessed for co-morbid
depression were awareness by the GP that depression
could affect cognitive function, that depression often oc-
curs with dementia, and that a depression assessment
should form part of the dementia diagnosis process (Know-
ledge), as summed up by the following comment: ‘… de-
pression can cause … poor concentration and memory
impairment and, you know, sitting around not wanting to
do anything and … all of those sort of things, so you’d really
have to exclude that or … make some sort of assessment
for that as well’ (GP 14 – Rural).
Those GPs who used general clinical indicators to
assess for co-morbid depression rather than using a
validated depression scale (Category 2) reported that val-
idated scales provided no additional useful diagnostic in-
formation and as such offered no advantage over their
general clinical assessment (Beliefs about consequences).
This is illustrated in the following comments: ‘No, but
depression is depression. In fact most of the time you
don’t need a specific, you know, depression scale to
diagnose the patient. So we do it clinically’ (GP 21 –
Metro); ‘Oh, look, I was trying to use those so-called
tools… but I found them no better than my intuition’ (GP
09 – Rural). Lack of experience or training in the use of
validated scales possibly contributed to the preference for
general clinical assessment (Skills). For example:‘Probably through lack of training in the use of them.
… I mean, if I was brought up using them, and experi-
enced positive benefits from them, then I may be more
willing to use them. .... But I have no experience with
them in training’ (GP 03 – Rural).
This lack of experience or training may also have con-
tributed to the discomfort expressed by some clinicians
when administering a validated depression scale (Emo-
tion; Beliefs about capabilities). A belief that patients
were able to self-report depression, making use of a vali-
dated scale unnecessary, was another reason cited for
not using such a tool (Beliefs about consequences).
Those who conducted a depression assessment using a
validated tool were aware of the tests to use and had
access to them (Knowledge; Environmental context and re-
sources), were trained or experienced in using the tools
(Skills), and were confident and comfortable administering
them (Beliefs about capabilities; Emotion).
Category 3. Co-morbid depression not assessed by GP
The most frequently offered reason for not assessing co-
morbid depression was that the GP was not aware that a
depression assessment should form part of the diagnosis
of dementia (Knowledge). Some GPs believed a depression
assessment only needs to be conducted with patients in
whom depression is suspected rather than being a routine
part of the diagnosis process for all patients with suspected
dementia (Knowledge). In some instances, for other GPs, a
depression assessment may not be conducted because the
clinician, although being aware of the need for it, forgets to
do so (Memory, attention and decision processes).
In cases where the GP referred a patient to ACAS or a
specialist without assessing their cognitive function they
were also unlikely to assess the patient for co-morbid
depression.
No differences were found between metropolitan and
regional/rural GPs in terms of their practice and key
influencing factors relating to assessment of co-morbid
depression in patients with suspected dementia.
An overview of the influencing factors relating to the
other recommended behaviours investigated in this study is
contained in Additional file 2.
Discussion
This research has explored the reported practice and
theoretical explanations for why GPs may or may not
practice in a manner consistent with recommended be-
haviours for the diagnosis and management of dementia.
While the majority of GPs reported conducting a formal
cognitive assessment using a validated scale, few GPs re-
ported assessing co-morbid depression using a validated
tool consistent with recommended guidelines. These
findings are consistent with research suggesting that as-
sessment of cognitive function by use of a MMSE is one
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suspect cognitive impairment [14,44] but that GPs in
general prefer to use general clinical indicators rather
than use of validated tools if they assess patients for co-
morbid depression [45,46].
While previous studies have investigated barriers to
the diagnosis and management of patients with dementia
in primary care settings in Europe and North America
[22,47-57], few studies have examined barriers to specific
clinical behaviours, such as conduct of formal cogni-
tive or depression assessments using validated tools
[48,49,51,55,57], and no other study to our knowledge
has reported an investigation of the barriers and
enablers using a theoretical approach to guide data
collection and analysis.
Awareness of the need to undertake a formal cognitive
assessment using a validated scale (Knowledge), having
the necessary skills to do so (Skills; Beliefs about capabil-
ities), and time and resource availability (Environmental
context and resources) were the main factors enabling
conduct of formal cognitive assessment using a validated
scale by GPs in this study. Most GPs reported conduct-
ing this assessment as part of their normal routine for
evaluating patients in whom they suspect cognitive im-
pairment or dementia (Behavioural regulation). This is
consistent with previous findings in which US primary
care physicians have reported conducting formal cogni-
tive tests as part of their standard assessment procedures
[48]. In the present study, key barriers to using a vali-
dated tool to conduct a cognitive assessment related to
negative beliefs about the effect of using such a tool on
patients (Beliefs about consequences), perceived limitations
of the MMSE tool itself (Beliefs about consequences), and
GP discomfort in administering it (Emotion). A reluctance
to use formal cognitive tests because of concerns about
insulting or embarrassing patients, the belief that such tests
provide no additional information, and GP discomfort in
administering these tests are consistent with previous
reports [49,51,55,57]. Other barriers to formal cognitive as-
sessment identified in other studies consistent with our
findings include the time constraints in normal consulta-
tions and lack of GP skills in the use of formal cognitive
tests [51,57,58]. However, new factors not previously re-
ported were identified in this study. These included, for
example, GPs’ referral to specialists, directly or through
ACAS, for cognitive assessment and their reasons for doing
so (e.g., lack of time/resources to conduct MMSE; limited
confidence and skills in administering the MMSE them-
selves; being uncomfortable testing patients themselves; be-
lief that a specialist would provide an unbiased and
independent assessment). Also, factors influencing GPs’ fail-
ure to conduct themselves, or refer for, cognitive assess-
ment were identified (e.g., beliefs that cognitive impairment
was not sufficiently problematic so assessment perceived asunhelpful; refusal by patient or family; and GPs lacking
skills to convince the patient and/or family of the need for
assessment).
A key barrier to assessing co-morbid depression using
a validated tool identified in this study was the belief
that depression can be adequately assessed using general
clinical indicators. Other barriers included: that the use
of validated tools provided no additional useful informa-
tion (Beliefs about consequences); discomfort in using
validated tools (Emotion), possibly due to limited training,
experience or confidence in using them (Skills; Beliefs
about capabilities); limited awareness of the need for de-
pression assessment (Knowledge); and forgetting to con-
duct the assessment (Memory, attention and decision
processes). No previous studies to our knowledge have
identified barriers to this recommended clinical behaviour,
so these findings were important for informing our targeted
practice change strategy.
Unlike many previous studies using the TDF to ex-
plore possible explanations for implementation prob-
lems, both content and thematic analyses were used in
this study to analyse the interview data rather than use
of a single approach [31,34,36,37,39,59]. First, the pat-
tern of clinical behaviours that GPs engaged in, relating
to each guideline recommendation, was identified and
categorised using content analysis. For example, five cat-
egories of clinical behaviour were identified in relation
to the recommendation that a formal cognitive assess-
ment using a validated scale be conducted with individ-
uals with suspected cognitive impairment. Next, content
analysis of data within each category was conducted to
identify the factors (i.e., barriers and enablers) perceived
to influence the achievement of the recommended be-
haviour on the basis of identified categories (e.g., in in-
stances where GPs report conducting no assessment of
cognitive function, or in instances where GPs report
conducting a cognitive assessment using a method or
use of clinical criteria rather than a validated scale).
Finally, the identified factors within each category were
thematically mapped to the domains of the TDF. Thus
our analysis drew upon both inductive ‘bottom up’ and
deductive ‘top down’ approaches (the latter informed by
the TDF) and enabled exploration of the theoretical ex-
planations for why GPs may or may not practice in a
manner consistent with recommended behaviours,
detailed at the level of the identified categories of
clinician behaviour (e.g., see Figure 1). While we found
this approach useful in informing the design of our
implementation intervention, further investigation is
needed to determine the optimal approach to ana-
lysis when using the TDF to identify theoretical ex-
planations for implementation problems and when
designing implementation interventions to support
practice change.
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ence practice for managing patients with suspected cog-
nitive impairment and dementia, there were some
limitations. First, we invited a total of 700 GPs but con-
ducted interviews with only 30 participants (4%) to
achieve data saturation. The low response rate to our in-
vitations may have been due to some individuals in the
sampling frame being ineligible (i.e., not currently man-
aging patients with suspected cognitive impairment or
dementia) or possibly due to a perception that the clin-
ical issue was of low priority given the diverse range of
clinical problems that GPs manage given the multiple
demands on GP time. However, despite this low re-
sponse rate, participants varied on a range of variables
including sex, years of experience, practice size, experi-
ence in caring for patients with dementia and geographical
location, and saturation of themes was reached suggesting
the findings are comprehensive in their coverage of the
issues. Second, data presented in this study represent the
perceptions and accounts of participants interviewed and,
as such, may not represent actual influences on practice.
Finally, only 20% of the interviews were coded in duplicate.
A strength of the study was that researchers achieved a
high level of consistency in terms of the barriers and
enablers coded as being relevant.
Findings from this paper have been used to develop a
targeted, theory-informed implementation intervention
to support evidence-informed diagnosis and manage-
ment of dementia by GPs. Using a theoretical approach
enables a more comprehensive assessment of factors in-
fluencing practice and informs the matching of interven-
tion components and behaviour change techniques to
identified factors, and assists in conceptualising the
pathway of change needed for the intervention to work
[26,60]. An intervention informed by this study is being
tested in a cluster randomised trial, the IRIS trial [40].Conclusions
To our knowledge, this is the first study to use a theoret-
ical approach to investigate the barriers and enablers to
guideline-recommended diagnosis and management of
dementia in general practice. It has identified key factors
likely to influence uptake of evidence-based dementia
guidelines in Australian general practice. The results have
been used to inform the development of a targeted, theory-
informed implementation intervention aimed at supporting
practice change in line with best evidence.Additional files
Additional file 1: Interview guide. This file includes the interview
guide used for GP interviews.Additional file 2: Barriers and enablers to other recommended
behaviours elicited in interviews. This file includes the barriers and
enablers to other recommended behaviours elicited in interviews.
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